Please login to the form below
Almirall
This page shows the latest Almirall news and features for those working in and with pharma, biotech and healthcare.
Almirall looks to crowdsource new skin health treatments
Almirall looks to crowdsource new skin health treatments. Launches open innovation platform AlmirallShare. ... Spanish pharma company Almirall has set up an online open innovation platform through which it hopes to find skin health solutions.
Latest news
-
Almirall launches story campaign to raise rosacea awareness
Almirall launches story campaign to raise rosacea awareness. The Red Girl highlights the negative psychological effects of the disease. ... After acquiring Poli Group in 2015, Almirall obtained a dermatology focused R&D structure including its rosacea
-
Finalists revealed for Communiqué Awards 2016
The Burning Issue. by Red Door Unlimited. for Almirall. Creating a faithful following.
-
Pharma needs to 'better articulate' its value to society
Speaking at the Eyeforpharma conference in Barcelona this morning Almirall's CEO Eduardo Sanchiz said: "Let's recognise and be proud that few other industries provide the value to society that
-
Golden night for Saatchi & Saatchi at the PM Society Awards
2015 PM Society Awards winners (Golds). Craft Award for Direct Mail- bmore creative for Almirall.
-
AstraZeneca scores in final lung disease drug trials
from big players such as Boehringer, GlaxoSmithKline, Novartis and Forest/Almirall.
More from news
Approximately 11 fully matching, plus 67 partially matching documents found.
Latest Intelligence
-
Deal Watch March 2017
12. Symatese. Almirall. Development collaboration. Customised products in aesthetics. 8. AgaImmune.
-
Deal Watch December 2016
510. Nuevolution (Denmark). Almirall (Spain). Research collaboration. RORγt inhibitors for inflammatory skin diseases and psoriatic arthritis. ... $21m plus $80m equity. Biosimilars. Nuevolution. Almirall. $453m. $11.8m. Inhibitors to transcription
-
Deal Watch October 2016
$575m. $198m. 2.9. Respiratory 2014. Almirall. Products pipeline. $2, 100 milestones.
-
Deal Watch July 2016
Celyad. $311m. $12.5m. Almirall. Patagonia. $28m. $3.5m. Petra Pharma. Sprint BioScience. ... Almirall's initial expenditure has been a more modest $3.5m for this earlier stage product.
-
Stronger together
Also speaking at the eyeforpharma conference was Almirall's CEO Eduardo Sanchiz, who noted that, while patient-centricity is often talked about in the industry, “ we have difficulties putting it in
More from intelligence
Approximately 2 fully matching, plus 10 partially matching documents found.
Latest appointments
-
Almirall appoints Peter Guenter as its CEO
Almirall appoints Peter Guenter as its CEO. He joins from Sanofi where he was executive vice president. ... I am convinced he will bring what is needed to develop Almirall to the next level.”.
-
Ron Menezes joins Almirall’s Aqua Pharmaceuticals
Ron Menezes joins Almirall’ s Aqua Pharmaceuticals. He joins the US dermatology group as its president and general manager. ... Sanchiz added: “Almirall continues to consider Aqua as a very important platform in the US market to support existing and
-
ThermiGen appoints Vladimir Paul-Blanc as president
ThermiGen appoints Vladimir Paul-Blanc as president. He will also serve as the Almirall-owned firm's general manager. ... He said: “I couldn’t be more excitied to join Almirall and work with the Thermi organisation.
-
Caldan Therapeutics bolsters senior team
Most recently, Dr Connolly served as scientific leader with Almirall, based in Barcelona, Spain.
-
Red Door promotes Matt Lowe and Katy Pogson
Aldous joined Red Door in 2011 from Red Health as a senior account manager and currently leads accounts for Sanofi, MSD, Baxter, Almirall and Astellas.
More from appointments
Approximately 5 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Solaris Health
Abbvie. Aimmune. Almirall. Ascensia. BD. Bio-Medical Research. Desitin. Ferring. Flexyfoot. Gedeon Richter.
-
HAVAS LYNX
AbbVie. Alexion. Almirall. Astellas. AstraZeneca. Bayer. Eisai. Genzyme. Janssen. Kowa. Lilly.
-
nitrogen
CHISWICK OFFICE:. MARLOW OFFICE:. Abbott Nutrition. Almirall. Astellas. Astellas. Covidien. AstraZeneca.
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
Featured jobs
-
Account Director at PAREXEL MedCom
-
Competitive Salary
-
Medical Editor
-
Great salary and benefits
-
Principal Medical Writer
-
Great salary and benefits
- Account Director, Healthcare Communications
-
£50, 000 - £60, 000
- Scientific Team Leader, Medical Education
-
£55, 000 – £70, 000 benefits
-
Editorial Director - BioScience
-
Competitive Salary
-
Account Director
-
Salary TBC
- Scientific Director, Medical Communications
-
£60 – 70, 000 benefits
- Digital Account Director – Healthcare Communications
-
£50 – 60, 000 benefits
Subscribe to our email news alerts
- Court throws out Allergan's patent deal with Native American tribe
- Harnessing the power of core elements to optimise market access
- BMS closes in on another US indication for Opdivo
- Health and wellbeing agency Salt Thinking launched
- Ceri James joins AZoNetwork as chief operating officer
- US biotech Translate Bio appoints Daniella Beckman
PMHub
Accession
Accession was a born from a passion and a vision. A passion to harness the power of market access to...
Latest intelligence
- Harnessing the power of core elements to optimise market access
- This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...
- So how do you really engage with patients?
- The most valuable insights from patient engagement are the most unexpected ones. Simple things, which may seem unimportant to you, may be the key to making patients’ lives easier and...
- Avoiding data pitfalls in clinical research
- Genomics sequencing and sensors will present new challenges...
Quick links
Infographics
